vida: extract claims from 2026-01-21-aha-2026-heart-disease-stroke-statistics-update

- Source: inbox/queue/2026-01-21-aha-2026-heart-disease-stroke-statistics-update.md
- Domain: health
- Claims: 2, Entities: 0
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>

domains/health/hypertension-shifted-from-secondary-to-primary-cvd-mortality-driver-since-2022.md

@@ -0,0 +1,17 @@
+---
+type: claim
+domain: health
+description: The doubling of hypertensive disease mortality since 1999 and its surpassing of ischemic heart disease as a contributing cause represents a fundamental change in CVD epidemiology
+confidence: proven
+source: American Heart Association 2026 Statistics Update, 2023 US data
+created: 2026-04-04
+title: Hypertension became the primary contributing cardiovascular cause of death in the US since 2022 marking a shift from acute ischemia to chronic metabolic disease as the dominant CVD mortality driver
+agent: vida
+scope: structural
+sourcer: American Heart Association
+related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]", "[[Big Food companies engineer addictive products by hacking evolutionary reward pathways creating a noncommunicable disease epidemic more deadly than the famines specialization eliminated]]"]
+---
+
+# Hypertension became the primary contributing cardiovascular cause of death in the US since 2022 marking a shift from acute ischemia to chronic metabolic disease as the dominant CVD mortality driver
+
+Hypertensive disease age-adjusted mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023. Since 2022, hypertension has become the #1 contributing cardiovascular cause of death in the US, surpassing ischemic heart disease. This represents a fundamental epidemiological shift: the primary driver of CVD mortality is transitioning from acute ischemia (addressable through procedural interventions like stents, bypass surgery, and acute stroke care) to chronic hypertension (requiring behavioral modification, medication adherence, and structural interventions in diet and environment). The AHA notes that 1 in 3 US adults has hypertension and control rates have worsened since 2015. This shift has profound implications for healthcare strategy—it means the marginal return on acute care capacity is declining while the marginal return on chronic disease management and prevention is rising. The healthcare system's structural misalignment becomes visible: reimbursement, training, and infrastructure remain optimized for acute intervention while the binding constraint has shifted to chronic metabolic management.

domains/health/us-cvd-mortality-bifurcating-ischemic-declining-heart-failure-hypertension-worsening.md

@@ -1,34 +1,17 @@
 ---
 type: claim
 domain: health
-description: The divergent trends by CVD subtype reveal that excellent acute ischemic care coexists with worsening chronic cardiometabolic burden
+description: The divergent trends by CVD subtype show that procedural care improvements for acute ischemia coexist with worsening chronic metabolic disease burden
-confidence: experimental
+confidence: proven
-source: American Heart Association 2026 Statistics Update, 2023 data
+source: American Heart Association 2026 Statistics Update, 2023 US data
-created: 2026-04-03
+created: 2026-04-04
-attribution:
+title: US CVD mortality is bifurcating with ischemic heart disease declining while heart failure and hypertensive disease reach all-time highs revealing that aggregate improvement masks structural deterioration in cardiometabolic health
-  extractor:
+agent: vida
-    - handle: "vida"
+scope: structural
-  sourcer:
+sourcer: American Heart Association
-    - handle: "american-heart-association"
+related_claims: ["[[Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s]]", "[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[healthcare AI creates a Jevons paradox because adding capacity to sick care induces more demand for sick care]]"]
-      context: "American Heart Association 2026 Statistics Update, 2023 data"
 ---
 
-# US CVD mortality is bifurcating with ischemic heart disease and stroke declining while heart failure and hypertensive disease worsen creating aggregate improvement that masks structural deterioration in cardiometabolic health
+# US CVD mortality is bifurcating with ischemic heart disease declining while heart failure and hypertensive disease reach all-time highs revealing that aggregate improvement masks structural deterioration in cardiometabolic health
 
-The AHA 2026 statistics reveal a critical bifurcation pattern in US cardiovascular mortality. While overall age-adjusted CVD mortality declined 2.7% from 2022 to 2023 (224.3 → 218.3 per 100,000) and has fallen 33.5% since 1999, this aggregate improvement conceals divergent trends by disease subtype.
+The AHA 2026 report reveals a critical bifurcation in CVD mortality trends. While overall age-adjusted CVD mortality declined 33.5% from 1999 to 2023 (350.8 to 218.3 per 100,000), this aggregate improvement conceals opposing trends by disease subtype. Ischemic heart disease and cerebrovascular disease mortality both declined consistently over the study period. However, heart failure mortality reached an all-time high of 21.6 per 100,000 in 2023—exceeding even its 1999 baseline of 20.3 after declining to 16.9 in 2011. Hypertensive disease mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023, making hypertension the #1 contributing cardiovascular cause of death since 2022, surpassing ischemic heart disease. This pattern indicates that healthcare has become excellent at treating acute ischemic events (MI, stroke) through procedural interventions while simultaneously failing to address the upstream cardiometabolic drivers (obesity, hypertension, metabolic syndrome) that determine long-term healthspan. The bifurcation explains why life expectancy can improve (fewer people dying acutely) while population health deteriorates (more people living with chronic disease burden).
-
-Declining: Ischemic heart disease and cerebrovascular disease mortality both declined over the study period, with stroke deaths dropping for the first time in several years.
-
-Worsening: Heart failure mortality reached an all-time high of 21.6 per 100,000 in 2023—exceeding its 1999 baseline of 20.3 after declining to 16.9 in 2011. This represents a complete reversal, not stagnation. Hypertensive disease mortality doubled from 15.8 to 31.9 per 100,000 between 1999-2023, and since 2022 has become the #1 contributing cardiovascular cause of death, surpassing ischemic heart disease.
-
-This pattern is exactly what would be expected if healthcare excels at treating acute disease (MI, stroke) through procedural interventions while failing to address the underlying metabolic risk factors (obesity, hypertension, metabolic syndrome) that drive chronic cardiometabolic conditions. The bifurcation suggests that the binding constraint on further CVD mortality reduction has shifted from acute care capability to chronic disease prevention and management—domains requiring behavioral and structural intervention rather than procedural excellence.
-
----
-
-Relevant Notes:
-- [[hypertensive-disease-mortality-doubled-1999-2023-becoming-leading-contributing-cvd-cause]]
-- [[us-heart-failure-mortality-reversed-1999-2023-exceeding-baseline-despite-acute-care-improvements]]
-- [[hypertension-related-cvd-mortality-doubled-2000-2023-despite-available-treatment-indicating-behavioral-sdoh-failure]]
-
-Topics:
-- [[_map]]